DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Tourbah A, Lebrun-Frenay C, Edan G. , et al; MS-SPI study group.
MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: a randomised, double-blind, placebo-controlled study.
Mult Scler 2016;
22 (13) 1719-1731
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.